Peter J Schnorr
Overview
Explore the profile of Peter J Schnorr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
354
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Friedrich A, Kakuturu J, Schnorr P, Beyer Jr D, Palesty J, Dickson E, et al.
Thromb Res
. 2017 Aug;
158:16-18.
PMID: 28783512
No abstract available.
2.
Weiskopf K, Anderson K, Ito D, Schnorr P, Tomiyasu H, Ring A, et al.
Cancer Immunol Res
. 2016 Nov;
4(12):1072-1087.
PMID: 27856424
Cancer immunotherapies hold much promise, but their potential in veterinary settings has not yet been fully appreciated. Canine lymphomas are among the most common tumors of dogs and bear remarkable...
3.
Weiskopf K, Schnorr P, Pang W, Chao M, Chhabra A, Seita J, et al.
Microbiol Spectr
. 2016 Oct;
4(5).
PMID: 27763252
The hematopoietic stem cell (HSC) is a multipotent stem cell that resides in the bone marrow and has the ability to form all of the cells of the blood and...
4.
Weiskopf K, Jahchan N, Schnorr P, Cristea S, Ring A, Maute R, et al.
J Clin Invest
. 2016 Jun;
126(7):2610-20.
PMID: 27294525
Small-cell lung cancer (SCLC) is a highly aggressive subtype of lung cancer with limited treatment options. CD47 is a cell-surface molecule that promotes immune evasion by engaging signal-regulatory protein alpha...
5.
Krampitz G, George B, Willingham S, Volkmer J, Weiskopf K, Jahchan N, et al.
Proc Natl Acad Sci U S A
. 2016 Apr;
113(16):4464-9.
PMID: 27035983
Pancreatic neuroendocrine tumors (PanNETs) are a type of pancreatic cancer with limited therapeutic options. Consequently, most patients with advanced disease die from tumor progression. Current evidence indicates that a subset...
6.
Weiskopf K, Ring A, Schnorr P, Volkmer J, Volkmer A, Weissman I, et al.
Oncoimmunology
. 2013 Dec;
2(9):e25773.
PMID: 24319639
CD47 transduces inhibitory signals through signal-regulatory protein α (SIRPα), a plasma membrane receptor expressed by macrophages. Many cancers upregulate CD47 to evade immunosurveillance. We have recently engineered SIRPα variants that...